| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abdominal Imaging in pregnancy (maternal and foetal risks)
|
Flanagan, Emma
|
|
|
48-49 |
C |
p.
|
artikel
|
| 2 |
Acute severe ulcerative colitis: State of the art treatment
|
Gisbert, Javier P.
|
|
2018
|
48-49 |
C |
p. 59-69
|
artikel
|
| 3 |
Advanced strategies for intensive care management of acute liver failure
|
Saner, Fuat H.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 4 |
Advances towards gastric cancer screening: Novel devices and biomarkers
|
Lopes, Catarina
|
|
|
48-49 |
C |
p.
|
artikel
|
| 5 |
Adverse effects of immunosuppression after liver transplantation
|
Noble, Johan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 6 |
Alcohol and other substance use after liver transplant
|
Winder, Gerald Scott
|
|
|
48-49 |
C |
p.
|
artikel
|
| 7 |
An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management
|
Smith, Padraic
|
|
|
48-49 |
C |
p.
|
artikel
|
| 8 |
Applications of endoscopic vacuum therapy in the lower gastrointestinal tract: Tips and tricks and a review of the literature
|
Kouladouros, Konstantinos
|
|
|
48-49 |
C |
p.
|
artikel
|
| 9 |
Artificial Intelligence for gastrointestinal endoscopy: When technology meets our needs!
|
Hassan, Cesare
|
|
|
48-49 |
C |
p.
|
artikel
|
| 10 |
Artificial intelligence in biliopancreatic endoscopy: Is there any role?
|
Ahmad, Omer F.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 11 |
Artificial intelligence in early screening for esophageal squamous cell carcinoma
|
Yan, Si-yan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 12 |
Artificial intelligence: Thinking outside the box
|
Tontini, Gian Eugenio
|
|
|
48-49 |
C |
p.
|
artikel
|
| 13 |
Barrett esophagus: What to expect from Artificial Intelligence?
|
Ebigbo, Alanna
|
|
|
48-49 |
C |
p.
|
artikel
|
| 14 |
Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives
|
Provoost, Nanda
|
|
|
48-49 |
C |
p.
|
artikel
|
| 15 |
Basic concepts in the management of Acute Liver Failure
|
Auzinger, Georg
|
|
|
48-49 |
C |
p.
|
artikel
|
| 16 |
Biobetters and biosimilars in inflammatory bowel disease
|
Fanizza, Jacopo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 17 |
Biosimilars in ulcerative colitis: When and for who?
|
Ilias, Akos
|
|
2018
|
48-49 |
C |
p. 35-42
|
artikel
|
| 18 |
Can IL-23 be a good target for ulcerative colitis?
|
Allocca, Mariangela
|
|
2018
|
48-49 |
C |
p. 95-102
|
artikel
|
| 19 |
“Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?”
|
Varyani, Fumi
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 20 |
Can we move directly from 5-ASA to a biologic agent in ulcerative colitis?
|
Hindryckx, Pieter
|
|
2018
|
48-49 |
C |
p. 9-15
|
artikel
|
| 21 |
Cardiovascular and metabolic disease in the liver transplant recipient
|
Kim, Nathan G.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 22 |
Cell therapy in congenital inherited hepatic disorders
|
Anand, Hanish
|
|
|
48-49 |
C |
p.
|
artikel
|
| 23 |
Changes to gastrointestinal function after surgery for colorectal cancer
|
Lam, David
|
|
|
48-49 |
C |
p.
|
artikel
|
| 24 |
Changing epidemiology and etiology of upper and lower gastrointestinal bleeding
|
Oakland, Kathryn
|
|
|
48-49 |
C |
p.
|
artikel
|
| 25 |
Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer
|
van den Ende, Tom
|
|
2018
|
48-49 |
C |
p. 45-52
|
artikel
|
| 26 |
Chronic diarrhoea in an oncology patient – Clinical assessment and decision making
|
Fernandes, Darren CR.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 27 |
Chronic pancreatitis and nutritional support
|
Campagnola, Pietro
|
|
|
48-49 |
C |
p.
|
artikel
|
| 28 |
Coagulopathy in acute liver failure
|
Roy, Akash
|
|
|
48-49 |
C |
p.
|
artikel
|
| 29 |
Colorectal cancer prevention in patients with ulcerative colitis
|
Lopez, Anthony
|
|
2018
|
48-49 |
C |
p. 103-109
|
artikel
|
| 30 |
Colorectal polyp characterization with endocytoscopy: Ready for widespread implementation with artificial intelligence?
|
Barua, Ishita
|
|
|
48-49 |
C |
p.
|
artikel
|
| 31 |
Colorectal polyp characterization with standard endoscopy: Will Artificial Intelligence succeed where human eyes failed?
|
Parsa, Nasim
|
|
|
48-49 |
C |
p.
|
artikel
|
| 32 |
Complications and management of interventional endoscopic ultrasound: A critical review
|
Fabbri, Carlo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 33 |
Complications related to third space endoscopic procedures
|
El Abiad, Rami
|
|
|
48-49 |
C |
p.
|
artikel
|
| 34 |
Congenital disorders of intestinal digestion and absorption (sugars, proteins, lipids, ions)
|
Peretti, Noel
|
|
|
48-49 |
C |
p.
|
artikel
|
| 35 |
Congenital enteropathies involving defects in enterocyte structure or differentiation
|
Goulet, Olivier
|
|
|
48-49 |
C |
p.
|
artikel
|
| 36 |
Congenital gastrointestinal disorders. Why is it relevant to adult gastroenterologists?
|
Gottrand, F.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 37 |
Considerations in case of suspected anastomotic leakage in the lower GI tract
|
de Wit, A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 38 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 39 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 40 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 41 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 42 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 43 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 44 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 45 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 46 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 47 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 48 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 49 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 50 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 51 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 52 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 53 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 54 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 55 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 56 |
Copyright Information
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 57 |
CORRIGENDUM TO ‘immunosuppression in liver and intestinal transplantation’
|
Lerut, Jan P.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 58 |
Cost effectiveness analysis of Barrett's esophagus screening: A systematic review
|
Matchett, Caroline L.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 59 |
Cost-effectiveness of prevention and early detection of gastric cancer in Western countries
|
Lansdorp-Vogelaar, Iris
|
|
|
48-49 |
C |
p.
|
artikel
|
| 60 |
Cost-effectiveness of upper endoscopy for gastric cancer screening and surveillance in Western populations
|
Kapteijn, N.E.A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 61 |
Cricopharyngeal achalasia and upper oesophageal endoscopic myotomy (CP-POEM)
|
Albeniz, Eduardo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 62 |
Curative criteria for endoscopic treatment of colorectal cancer
|
Quénéhervé, Lucille
|
|
|
48-49 |
C |
p.
|
artikel
|
| 63 |
Curative criteria for endoscopic treatment of gastric cancer
|
Cunha Neves, João A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 64 |
Curative criteria for endoscopic treatment of oesophageal adenocarcinoma
|
Maan, Annemijn D.I.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 65 |
Curative criteria for endoscopic treatment of oesophageal squamous cell cancer
|
Iizuka, Toshiro
|
|
|
48-49 |
C |
p.
|
artikel
|
| 66 |
Definitions, etiopathogenesis and epidemiology of ALF
|
Biswas, Sagnik
|
|
|
48-49 |
C |
p.
|
artikel
|
| 67 |
De novo and recurrent liver disease
|
Ip, Stephen
|
|
|
48-49 |
C |
p.
|
artikel
|
| 68 |
De novo and recurrent malignancy
|
Shalaby, Sarah
|
|
|
48-49 |
C |
p.
|
artikel
|
| 69 |
Detection of flat colorectal neoplasia by artificial intelligence: A systematic review
|
Yamada, Masayoshi
|
|
|
48-49 |
C |
p.
|
artikel
|
| 70 |
Diagnosis and management of mid-gut (small-bowel) diseases: The state of the art in 2023
|
Despott, Edward J.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 71 |
Diagnosis and management of small-bowel bleeding
|
Pennazio, Marco
|
|
|
48-49 |
C |
p.
|
artikel
|
| 72 |
Dietary factors involved in GERD management
|
Fox, Mark
|
|
|
48-49 |
C |
p.
|
artikel
|
| 73 |
Digestive outcomes in Cystic fibrosis
|
Ley, Delphine
|
|
|
48-49 |
C |
p.
|
artikel
|
| 74 |
Early detection of gastric cancer beyond endoscopy - new methods
|
Leja, Mārcis
|
|
|
48-49 |
C |
p.
|
artikel
|
| 75 |
Early detection of pancreatobiliary cancers: How to unveil a silent epidemic to change the outcomes - Preface
|
Vanella, Giuseppe
|
|
|
48-49 |
C |
p.
|
artikel
|
| 76 |
Early diagnosis of gastric cancer: Endoscopy and artificial intelligence
|
Gonçalves, N.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 77 |
Early gastric cancer and Artificial Intelligence: Is it time for population screening?
|
Arribas Anta, Julia
|
|
|
48-49 |
C |
p.
|
artikel
|
| 78 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 79 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 80 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 81 |
Editorial Board
|
|
|
2018
|
48-49 |
C |
p. ii
|
artikel
|
| 82 |
Editorial Board
|
|
|
2018
|
48-49 |
C |
p. ii
|
artikel
|
| 83 |
Editorial Board
|
|
|
2018
|
48-49 |
C |
p. ii
|
artikel
|
| 84 |
Editorial Board
|
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 85 |
Editorial Board
|
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 86 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 87 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 88 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 89 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 90 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 91 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 92 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 93 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 94 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 95 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 96 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 97 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 98 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 99 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 100 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 101 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 102 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 103 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 104 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 105 |
Editorial Board
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 106 |
Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease
|
Wieringa, J.W.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 107 |
Effect of frequently prescribed drugs on gastric cancer risk
|
Weltermann, Theresa
|
|
|
48-49 |
C |
p.
|
artikel
|
| 108 |
Effect of the immune microenvironment on prognosis in oesophageal adenocarcinoma
|
Peristeri, Dimitra V.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 109 |
Emerging indications for third space endoscopy
|
Shah, Rahil H.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 110 |
Endoscopic management of dysplasia and early oesophageal cancer
|
Zeki, S.S.
|
|
2018
|
48-49 |
C |
p. 27-36
|
artikel
|
| 111 |
Endoscopic management of intraprocedural bleeding during endoscopic interventions
|
Alali, Ali A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 112 |
Endoscopic management of nonvariceal upper gastrointestinal bleeding
|
Cañamares-Orbís, Pablo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 113 |
Endoscopic management of surgical complications
|
Goyal, Mayank
|
|
|
48-49 |
C |
p.
|
artikel
|
| 114 |
Endoscopic pyloromyotomy for treatment of gastroparesis: A new standard or still an experimental approach?
|
Vasatko, Martin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 115 |
Endoscopic removal of gastrointestinal lesions by using third space endoscopy techniques
|
Cecinato, Paolo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 116 |
Endoscopic resection for residual oesophageal neoplasia after definitive chemoradiotherapy
|
Honing, Judith
|
|
|
48-49 |
C |
p.
|
artikel
|
| 117 |
Endoscopic resection of residual rectal neoplasia after definitive chemoradiotherapy for rectal cancer
|
Klimkowski, Robert
|
|
|
48-49 |
C |
p.
|
artikel
|
| 118 |
Endoscopic retrograde cholangiopancreatography: A comprehensive review as a single diagnostic tool
|
Papaefthymiou, Apostolis
|
|
|
48-49 |
C |
p.
|
artikel
|
| 119 |
Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn's disease
|
Hart, Lara
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 120 |
Endoscopic suturing and clipping devices for defects in the GI tract
|
Papaefthymiou, Apostolis
|
|
|
48-49 |
C |
p.
|
artikel
|
| 121 |
Endoscopic ultrasonography: Enhancing diagnostic accuracy
|
Iglesias-Garcia, Julio
|
|
|
48-49 |
C |
p.
|
artikel
|
| 122 |
Endoscopic Ultrasound armamentarium for precise and early diagnosis of biliopancreatic lesions
|
Iglesias-Garcia, Julio
|
|
|
48-49 |
C |
p.
|
artikel
|
| 123 |
Endoscopic ultrasound guided access procedures following surgery
|
Elfert, Khaled
|
|
|
48-49 |
C |
p.
|
artikel
|
| 124 |
Endoscopic ultrasound guided biliary interventions
|
Dell’Anna, Giuseppe
|
|
|
48-49 |
C |
p.
|
artikel
|
| 125 |
Endoscopic ultrasound in the management of acute cholecystitis
|
Teh, J.L.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 126 |
Ensuring timely detection of neoplastic transformation by surveilling chronic pancreatitis
|
Vujasinovic, Miroslav
|
|
|
48-49 |
C |
p.
|
artikel
|
| 127 |
Esophageal squamous dysplasia and cancer: Is artificial intelligence our best weapon?
|
Hussein, Mohamed
|
|
|
48-49 |
C |
p.
|
artikel
|
| 128 |
EUS-guided celiac plexus neurolysis for pancreas cancer – Finally established or still under review?
|
Wyse, Jonathan M.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 129 |
EUS-guided intra-tumoral therapies
|
Marc, Barthet
|
|
|
48-49 |
C |
p.
|
artikel
|
| 130 |
EUS-guided transenteric pancreatic duct drainage
|
Giovannini, M.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 131 |
Evaluation and management of neurological complications in acute liver failure
|
Ansari, Nuruddin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 132 |
Evolution of our understanding of PBC
|
Tanaka, Atsushi
|
|
2018
|
48-49 |
C |
p. 3-9
|
artikel
|
| 133 |
Evolution of treatment targets in Crohn’s disease
|
White, Jonathan R.
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 134 |
Evolving strategies and goals of treatment in ulcerative colitis
|
Allocca, Mariangela
|
|
2018
|
48-49 |
C |
p. 1-2
|
artikel
|
| 135 |
Familial and hereditary gastric cancer, an overview
|
Carneiro, Fátima
|
|
|
48-49 |
C |
p.
|
artikel
|
| 136 |
Familial colorectal cancer
|
Mangas-Sanjuan, Carolina
|
|
|
48-49 |
C |
p.
|
artikel
|
| 137 |
Follow-up of liver transplant recipients
|
Neuberger, James
|
|
|
48-49 |
C |
p.
|
artikel
|
| 138 |
Food elimination diets in eosinophilic esophagitis: Practical tips in current management and future directions
|
Visaggi, Pierfrancesco
|
|
|
48-49 |
C |
p.
|
artikel
|
| 139 |
Futures perspectives and therapeutic applications
|
Monino, Laurent
|
|
|
48-49 |
C |
p.
|
artikel
|
| 140 |
Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) – A Helicobacter-opposite point
|
Tacheci, Ilja
|
|
|
48-49 |
C |
p.
|
artikel
|
| 141 |
Gastric cancer- endoscopic treatment of early lesions, the West learns from the East
|
Prinz, Friederike
|
|
|
48-49 |
C |
p.
|
artikel
|
| 142 |
Gastrointestinal aspects of Peutz-Jeghers syndrome
|
Latchford, A.R.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 143 |
Gastrointestinal manifestations in PTEN hamartoma tumor syndrome
|
D'Ermo, Giuseppe
|
|
|
48-49 |
C |
p.
|
artikel
|
| 144 |
Gastrointestinal side effects of upper gastrointestinal cancer surgery
|
Antonowicz, S.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 145 |
Genetic landscape for screening and early diagnosis of pancreatic ductal adenocarcinoma: is there a signature?
|
Campa, Daniele
|
|
|
48-49 |
C |
p.
|
artikel
|
| 146 |
Geoepidemiology and (epi-)genetics in primary biliary cholangitis
|
Roberto, Rosa
|
|
2018
|
48-49 |
C |
p. 11-15
|
artikel
|
| 147 |
Gut microbiome and metabolic dysfunction-associated steatotic liver disease: Pathogenic role and potential for therapeutics
|
Garcia-Mateo, Sandra
|
|
|
48-49 |
C |
p.
|
artikel
|
| 148 |
Gut microbiome in children undergoing hematopoietic stem cell transplantation
|
Józefczuk, Paweł
|
|
|
48-49 |
C |
p.
|
artikel
|
| 149 |
Gut microbiota in colorectal cancer: From pathogenesis to clinic
|
Fusco, William
|
|
|
48-49 |
C |
p.
|
artikel
|
| 150 |
Gut microbiota in inflammation and colorectal cancer: A potential Toolbox for Clinicians
|
Grellier, Nathan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 151 |
Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit
|
Koletzko, Leandra
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 152 |
Helicobacter pylori induced gastric carcinogenesis - The best molecular model we have?
|
Link, Alexander
|
|
|
48-49 |
C |
p.
|
artikel
|
| 153 |
Hereditary pancreatic cancer
|
Klatte, Derk C.F.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 154 |
Hirschsprung disease and Paediatric Intestinal Pseudo-obstruction
|
Chanpong, Atchariya
|
|
|
48-49 |
C |
p.
|
artikel
|
| 155 |
Historical perspective on needle development: From the past to the future
|
Karstensen, John Gásdal
|
|
|
48-49 |
C |
p.
|
artikel
|
| 156 |
How to close mucosal incisions?
|
Hustak, Rastislav
|
|
|
48-49 |
C |
p.
|
artikel
|
| 157 |
How to measure quality in capsule endoscopy
|
Salvi, Daniele
|
|
|
48-49 |
C |
p.
|
artikel
|
| 158 |
How to measure quality in device-assisted enteroscopy
|
Cortegoso Valdivia, Pablo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 159 |
How to measure quality in ERCP?
|
Ana Rita, Franco
|
|
|
48-49 |
C |
p.
|
artikel
|
| 160 |
How to measure quality in upper GI endoscopy
|
Romańczyk, Marcin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 161 |
IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?
|
Ma, Christopher
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 162 |
Immunosuppressants and immune modulators in luminal gastroenterology
|
Forbes, Alastair
|
|
|
48-49 |
C |
p.
|
artikel
|
| 163 |
Immunosuppression in gastroenterology and hepatology
|
Neuberger, James
|
|
|
48-49 |
C |
p.
|
artikel
|
| 164 |
Immunosuppression in liver and intestinal transplantation
|
Lerut, Jan P.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 165 |
Immunosuppression in liver transplant
|
Di Maira, Tommaso
|
|
|
48-49 |
C |
p.
|
artikel
|
| 166 |
Immunosuppressive drugs modes of action
|
Meneghini, Maria
|
|
|
48-49 |
C |
p.
|
artikel
|
| 167 |
Immunotherapy induced enterocolitis and gastritis – What to do and when?
|
Cheung, Vincent Ting Fung
|
|
|
48-49 |
C |
p.
|
artikel
|
| 168 |
Impact of artificial intelligence on colorectal polyp detection
|
Antonelli, Giulio
|
|
|
48-49 |
C |
p.
|
artikel
|
| 169 |
Impact of gastric cancer treatment on quality of life of patients
|
Schütte, Kerstin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 170 |
Improving prognosis in primary biliary cholangitis – Therapeutic options and strategy
|
Harms, Maren H.
|
|
2018
|
48-49 |
C |
p. 85-94
|
artikel
|
| 171 |
Increased risk of oesophageal squamous cell carcinoma development
|
Maan, Annemijn D.I.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 172 |
Infections in acute liver failure – Assessment, prevention, and management
|
Venkatakrishnan, Guhan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 173 |
Inherited pancreatic exocrine insufficiency and pancreatitis: When children transition to adult care
|
Scheers, Isabelle
|
|
|
48-49 |
C |
p.
|
artikel
|
| 174 |
Integrating artificial intelligence with endoscopic ultrasound in the early detection of bilio-pancreatic lesions: Current advances and future prospects
|
Tacelli, Matteo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 175 |
Interfering with leukocyte trafficking in Crohn's disease
|
Biswas, Sujata
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 176 |
In the absence of head-to-head trials, what do real world studies tell us about the comparative effectiveness of biologics in Crohn's disease
|
Meserve, Joseph
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 177 |
Introduction
|
Arcidiacono, Paolo Giorgio
|
|
|
48-49 |
C |
p.
|
artikel
|
| 178 |
Introduction to care of the liver transplant recipient
|
Neuberger, James M.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 179 |
Is PBC a viral infectious disease?
|
Mason, Andrew L.
|
|
2018
|
48-49 |
C |
p. 27-39
|
artikel
|
| 180 |
Is there still a role for the surgeon in the management of gastrointestinal bleeding ?
|
Donohoe, Claire L.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 181 |
JAK inhibitors: Novel developments in management of ulcerative colitis
|
Fiorino, Gionata
|
|
2018
|
48-49 |
C |
p. 89-93
|
artikel
|
| 182 |
Jejunal access for enteral nutrition: A practical guide for percutaneous endoscopic gastrostomy with jejunal extension and direct percutaneous endoscopic jejunostomy
|
Bourgeois, Amélie
|
|
|
48-49 |
C |
p.
|
artikel
|
| 183 |
Juvenile polyposis: Focus on less described manifestations
|
Saurin, Jean-Christophe
|
|
|
48-49 |
C |
p.
|
artikel
|
| 184 |
Juvenile polyposis syndrome: An overview
|
Dal Buono, Arianna
|
|
|
48-49 |
C |
p.
|
artikel
|
| 185 |
Liver assistive devices in acute liver failure: Current use and future directions
|
Dong, Victor
|
|
|
48-49 |
C |
p.
|
artikel
|
| 186 |
Liver transplantation in acute liver failure
|
Ichai, Philippe
|
|
|
48-49 |
C |
p.
|
artikel
|
| 187 |
Long term digestive outcome of œsophageal atresia
|
Aumar, Madeleine
|
|
|
48-49 |
C |
p.
|
artikel
|
| 188 |
Long-term outcomes of biliary atresia patients surviving with their native livers
|
Hukkinen, Maria
|
|
|
48-49 |
C |
p.
|
artikel
|
| 189 |
Lynch syndrome; towards more personalized management?
|
Llach, Joan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 190 |
Management after non-curative endoscopic resection of T1 rectal cancer
|
Dang, Hao
|
|
|
48-49 |
C |
p.
|
artikel
|
| 191 |
Management of ERCP complications
|
Pal, Partha
|
|
|
48-49 |
C |
p.
|
artikel
|
| 192 |
Management of familial adenomatous polyposis and MUTYH-associated polyposis; new insights
|
Aelvoet, Arthur S.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 193 |
Management of fistulas in the upper gastrointestinal tract
|
Matteo, Maria Valeria
|
|
|
48-49 |
C |
p.
|
artikel
|
| 194 |
Management of high risk T1 esophageal adenocarcinoma following endoscopic resection
|
Leclercq, Philippe
|
|
|
48-49 |
C |
p.
|
artikel
|
| 195 |
Management of high risk T1 gastric adenocarcinoma following endoscopic resection
|
Chaves, Jéssica
|
|
|
48-49 |
C |
p.
|
artikel
|
| 196 |
Management of iatrogenic perforations during endoscopic interventions in the hepato-pancreatico-biliary tract
|
Boonstra, Kirsten
|
|
|
48-49 |
C |
p.
|
artikel
|
| 197 |
Management of leakage and fistulas after bariatric surgery
|
Firkins, Stephen A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 198 |
Management of non-curative endoscopic resection of T1 colon cancer
|
Bernklev, Linn
|
|
|
48-49 |
C |
p.
|
artikel
|
| 199 |
Management of perforations during endoscopic resection
|
Alfarone, Ludovico
|
|
|
48-49 |
C |
p.
|
artikel
|
| 200 |
Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: Course ahead in research and clinical practice
|
Colomier, Esther
|
|
|
48-49 |
C |
p.
|
artikel
|
| 201 |
Microbial dysbiosis in gastric cancer: Association or causation?
|
Huma Arya, Pallavi
|
|
|
48-49 |
C |
p.
|
artikel
|
| 202 |
Microbiota in gastrointestinal malignancies
|
Bricca, Ludovica
|
|
|
48-49 |
C |
p.
|
artikel
|
| 203 |
Models and scores to predict adequacy of bowel preparation before colonoscopy
|
Fostier, Romane
|
|
|
48-49 |
C |
p.
|
artikel
|
| 204 |
Molecular modelling of the gastric barrier response, from infection to carcinogenesis
|
Traulsen, Jan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 205 |
Molecular pathways in the development and treatment of oesophageal cancer
|
Walker, Robert Charles
|
|
2018
|
48-49 |
C |
p. 9-15
|
artikel
|
| 206 |
Multi-modal and sequential treatment of liver cancer and its impact on the gastrointestinal tract
|
Seidensticker, Max
|
|
|
48-49 |
C |
p.
|
artikel
|
| 207 |
Multimodal cancer treatment with endoscopy
|
Kaminski, Michal F.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 208 |
Multi-modality management of defects in the gastrointestinal tract: Where the endoscope meets the scalpel
|
Pouw, Roos E.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 209 |
Multi-modality management of defects in the gastrointestinal tract: Where the endoscope meets the scalpel: Endoscopic vacuum therapy in the upper gastrointestinal tract
|
Pattynama, Lisanne M.D.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 210 |
Multimodal management of foregut neuroendocrine neoplasms
|
Zhou, Yichan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 211 |
Multimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma
|
Nabi, Zaheer
|
|
|
48-49 |
C |
p.
|
artikel
|
| 212 |
Navigating complexities and considerations for suspected anastomotic leakage in the upper gastrointestinal tract: A state of the art review
|
Kamarajah, Sivesh K.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 213 |
Navigating the learning landscape: Comprehensive training in third space endoscopy - training, techniques, and practical recommendations
|
Roser, D.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 214 |
Neoadjuvant chemoradiotherapy for resectable oesophageal cancer
|
Eyck, B.M.
|
|
2018
|
48-49 |
C |
p. 37-44
|
artikel
|
| 215 |
Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils
|
Singh, Siddharth
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 216 |
New agents for immunosuppression
|
Jefremow, André
|
|
|
48-49 |
C |
p.
|
artikel
|
| 217 |
New weapons for the management of perianal Crohn's disease
|
Cicerone, Clelia
|
|
|
48-49 |
C |
p.
|
artikel
|
| 218 |
Non-adherence and transition clinics
|
Kelly, Deirdre
|
|
|
48-49 |
C |
p.
|
artikel
|
| 219 |
Non-obstetric surgery in pregnancy (including bowel surgery and gallbladder surgery)
|
Arkenbosch, J.H.C.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 220 |
Non-technical skills in GI endoscopy as a unit quality measure
|
Haycock, Adam
|
|
|
48-49 |
C |
p.
|
artikel
|
| 221 |
Novel devices and biomarkers in screening for esophageal squamous cell cancer
|
Januszewicz, Wladyslaw
|
|
|
48-49 |
C |
p.
|
artikel
|
| 222 |
Novel imaging techniques in staging oesophageal cancer
|
Foley, Kieran
|
|
2018
|
48-49 |
C |
p. 17-25
|
artikel
|
| 223 |
Nutritional intervention in the management of non-alcoholic fatty liver disease
|
Brunetto, Maurizia R.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 224 |
Nutrition and gastroenterological support in end of life care
|
Schütte, Kerstin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 225 |
Nutrition in gastroenterology: Rising evidence and future directions
|
de Bortoli, Nicola
|
|
|
48-49 |
C |
p.
|
artikel
|
| 226 |
Nutrition in inflammatory bowel diseases; Is there a role?
|
Kaliora, Andriana C.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 227 |
Oesophagectomy: The expanding role of minimally invasive surgery in oesophageal cancer
|
van den Berg, J.W.
|
|
2018
|
48-49 |
C |
p. 75-80
|
artikel
|
| 228 |
Optimal management of the patient presenting with small bowel bleeding
|
Sey, Michael Sai Lai
|
|
|
48-49 |
C |
p.
|
artikel
|
| 229 |
Optimal timing of endoscopy in patients with acute upper gastrointestinal bleeding
|
Chaudhary, Sardar
|
|
|
48-49 |
C |
p.
|
artikel
|
| 230 |
Overcoming barriers to implementation of artificial intelligence in gastroenterology
|
Sutton, Richard A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 231 |
Palliation of dysphagia
|
van der Bogt, R.D.
|
|
2018
|
48-49 |
C |
p. 97-103
|
artikel
|
| 232 |
Pathophysiology of primary biliary cholangitis
|
Gulamhusein, Aliya F.
|
|
2018
|
48-49 |
C |
p. 17-25
|
artikel
|
| 233 |
Pathophysiology of the irritable bowel syndrome – Reflections of today
|
Hellström, Per M.
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 234 |
Patient experience as a quality marker in gastrointestinal endoscopy
|
Neilson, L.J.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 235 |
Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC)
|
Janmohamed, Ashnila
|
|
2018
|
48-49 |
C |
p. 71-83
|
artikel
|
| 236 |
PBC and related extrahepatic diseases
|
Floreani, Annarosa
|
|
2018
|
48-49 |
C |
p. 49-54
|
artikel
|
| 237 |
PBC-transplantation and disease recurrence
|
Nevens, Frederik
|
|
2018
|
48-49 |
C |
p. 107-111
|
artikel
|
| 238 |
Perface to special edition: Third space endoscopy
|
Martinek, Jan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 239 |
Peri-operative patient optimization for oesophageal cancer surgery – From prehabilitation to enhanced recovery
|
Zylstra, J.
|
|
2018
|
48-49 |
C |
p. 61-73
|
artikel
|
| 240 |
Per oral endoscopic myotomy for achalasia
|
de Sire, Roberto
|
|
|
48-49 |
C |
p.
|
artikel
|
| 241 |
Pharmacology, efficacy and safety of JAK inhibitors in Crohn’s disease
|
Ma, Christopher
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 242 |
Pitfalls in training and validation of deep learning systems
|
Eelbode, Tom
|
|
|
48-49 |
C |
p.
|
artikel
|
| 243 |
Plant-based diets in gastrointestinal diseases: Which evidence?
|
Mazzocchi, Samanta
|
|
|
48-49 |
C |
p.
|
artikel
|
| 244 |
POEM for non-achalasia spastic oesophageal motility disorders
|
Familiari, Pietro
|
|
|
48-49 |
C |
p.
|
artikel
|
| 245 |
POEM in the esophagus - How to deal with the post-POEM reflux
|
Ďuriček, Martin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 246 |
Post-endoscopy upper gastrointestinal cancer: Emerging data and opportunities to improve early detection
|
Ko, Mie Thu
|
|
|
48-49 |
C |
p.
|
artikel
|
| 247 |
Post liver transplant recurrent and de novo viral infections
|
Jothimani, Dinesh
|
|
|
48-49 |
C |
p.
|
artikel
|
| 248 |
Pouch surgery for ulcerative colitis in 2025: A narrative review
|
Vignali, Andrea
|
|
|
48-49 |
C |
p.
|
artikel
|
| 249 |
Preconception counseling of females with inflammatory bowel disease
|
Rottenstreich, Amihai
|
|
|
48-49 |
C |
p.
|
artikel
|
| 250 |
Predictive models in EUS/ERCP
|
Lattanzi, Barbara
|
|
|
48-49 |
C |
p.
|
artikel
|
| 251 |
Pre-existing liver disease in pregnancy: Cirrhosis, autoimmune hepatitis and liver transplantation
|
Milić, Sandra
|
|
|
48-49 |
C |
p.
|
artikel
|
| 252 |
Preface
|
Saigal, Sanjiv
|
|
|
48-49 |
C |
p.
|
artikel
|
| 253 |
Preface - Evolving approaches to the evaluation and management of Crohn’s disease
|
Jairath, Vipul
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 254 |
Preface - Functional gastrointestinal disorders
|
Hellström, Per M.
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 255 |
Preface – Gastrointestinal bleeding
|
Jairath, Vipul
|
|
|
48-49 |
C |
p.
|
artikel
|
| 256 |
Preface Hereditary disorders
|
van Leerdam, Monique E.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 257 |
Preface immunosuppression in gastroenterology and hepatology
|
Neuberger, James
|
|
|
48-49 |
C |
p.
|
artikel
|
| 258 |
Preface “Oesophageal cancer”
|
Wijnhoven, Bas
|
|
2018
|
48-49 |
C |
p. 1
|
artikel
|
| 259 |
Preface: Pregnancy in GI-disorders
|
Van der Woude, C.J.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 260 |
Preface - Primary Biliary Cholangitis
|
van Buuren, Henk R.
|
|
2018
|
48-49 |
C |
p. 1
|
artikel
|
| 261 |
Preface to issue ‘Quality in Endoscopy'
|
Regula, Jaroslaw
|
|
|
48-49 |
C |
p.
|
artikel
|
| 262 |
Preface to special edition: Microbiome, inflammation and cancer
|
Mullish, Benjamin H.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 263 |
Preface to special edition: Screening and Early diagnosis of upper gastrointestinal neoplastic lesions
|
Honing, J.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 264 |
Preface to special edition: The management of GI endoscopy complications
|
Longcroft-Wheaton, Gaius
|
|
|
48-49 |
C |
p.
|
artikel
|
| 265 |
Pregnancy and IBD: A practical guide for physicians
|
Freitas Queiroz, Natália Sousa
|
|
|
48-49 |
C |
p.
|
artikel
|
| 266 |
Prevention of delayed bleeding after resection of large colonic polyps
|
Htet, Hein
|
|
|
48-49 |
C |
p.
|
artikel
|
| 267 |
Prevention of post-ERCP complications
|
Triki, Lotfi
|
|
|
48-49 |
C |
p.
|
artikel
|
| 268 |
Primary biliary cholangitis and bone disease
|
Parés, Albert
|
|
2018
|
48-49 |
C |
p. 63-70
|
artikel
|
| 269 |
Prognostic modelling in IBD
|
Rimmer, Peter
|
|
|
48-49 |
C |
p.
|
artikel
|
| 270 |
Prognostic models and autoimmune liver diseases
|
D'Amato, Daphne
|
|
|
48-49 |
C |
p.
|
artikel
|
| 271 |
Prognostic models in acute liver failure-historic evolution and newer updates “prognostic models in acute liver failure”
|
Panackel, Charles
|
|
|
48-49 |
C |
p.
|
artikel
|
| 272 |
Prognostic models in alcohol-related liver disease and alcohol-related hepatitis
|
Musto, Jessica Ann
|
|
|
48-49 |
C |
p.
|
artikel
|
| 273 |
Prognostic models in end stage liver disease
|
Ferrarese, A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 274 |
Prognostic models – Their use and abuse
|
Neuberger, James
|
|
|
48-49 |
C |
p.
|
artikel
|
| 275 |
Prognostic models: What the statistician wants the clinician to know
|
Allen, Elisa
|
|
|
48-49 |
C |
p.
|
artikel
|
| 276 |
Progress in the treatment of cancer patients – don’t forget the gut feeling!
|
Bornschein, Jan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 277 |
Proton pump inhibitors for upper gastrointestinal bleeding
|
Kherad, Omar
|
|
|
48-49 |
C |
p.
|
artikel
|
| 278 |
Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome
|
Lindberg, Greger
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 279 |
Publisher's note
|
Wetherell, Victoria
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 280 |
Quality assessment in endoscopy “artificial intelligence in endoscopy”
|
Mori, Yuchi
|
|
|
48-49 |
C |
p.
|
artikel
|
| 281 |
Quality in endoscopy training
|
Anderson, John
|
|
|
48-49 |
C |
p.
|
artikel
|
| 282 |
Quality in EUS: for many but not for all
|
Fusaroli, Pietro
|
|
|
48-49 |
C |
p.
|
artikel
|
| 283 |
Quality in screening colonoscopy
|
Sztogrin-Pluta, Aleksandra
|
|
|
48-49 |
C |
p.
|
artikel
|
| 284 |
Quality of life after liver transplantation
|
Åberg, Fredrik
|
|
|
48-49 |
C |
p.
|
artikel
|
| 285 |
Quality parameters of colorectal polypectomy
|
Zessner-Spitzenberg, Jasmin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 286 |
Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options
|
Araujo, Isis K.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 287 |
Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options
|
Afifi, Ahmed N.A.M.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 288 |
Radiomics in early detection of bilio-pancreatic lesions: A narrative review
|
Casà, Calogero
|
|
|
48-49 |
C |
p.
|
artikel
|
| 289 |
Reaching the therapeutic ceiling in IBD: Can Advanced Combination Treatment (ACT) offer a solution?
|
Solitano, Virginia
|
|
|
48-49 |
C |
p.
|
artikel
|
| 290 |
Recent progress in gastric cancer prevention
|
Park, Jin Young
|
|
|
48-49 |
C |
p.
|
artikel
|
| 291 |
Recent progress in the understanding of gastric cancer – Do patients experience a benefit yet?
|
Bornschein, Jan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 292 |
Recommendations, evidence and sustainability of screening for pancreatic cancer in high-risk individuals
|
Bogdanski, Aleksander M.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 293 |
Reducing the burden of pancreatic cancer by surveilling mucinous cystic neoplasms: are we there yet?
|
De Stefano, Federico
|
|
|
48-49 |
C |
p.
|
artikel
|
| 294 |
Reducing the incidence of pancreatic cancer through radiofrequency ablation of mucinous cystic neoplasms: What is the evidence?
|
Kudaravalli, Pujitha
|
|
|
48-49 |
C |
p.
|
artikel
|
| 295 |
Reflux esophagitis, functional and non-functional
|
Bor, Serhat
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 296 |
Refractory ulcerative proctitis: How to treat it?
|
Pineton de Chambrun, Guillaume
|
|
2018
|
48-49 |
C |
p. 49-57
|
artikel
|
| 297 |
Regenerative medicine for childhood gastrointestinal diseases
|
Jones, Brendan C.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 298 |
Renal disease in the allograft recipient
|
Nevens, Frederik
|
|
|
48-49 |
C |
p.
|
artikel
|
| 299 |
Risk factors for oesophageal cancer
|
Xie, Shao-Hua
|
|
2018
|
48-49 |
C |
p. 3-8
|
artikel
|
| 300 |
Risk stratification and prognostic modelling in primary biliary cholangitis
|
Goet, Jorn C.
|
|
2018
|
48-49 |
C |
p. 95-106
|
artikel
|
| 301 |
Risk stratification in upper and upper and lower GI bleeding: Which scores should we use?
|
Oakland, Kathryn
|
|
|
48-49 |
C |
p.
|
artikel
|
| 302 |
Robot assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer
|
van der Sluis, Pieter Christiaan
|
|
2018
|
48-49 |
C |
p. 81-83
|
artikel
|
| 303 |
Role of Low-FODMAP diet in functional dyspepsia: “Why”, “When”, and “to Whom”
|
Rettura, Francesco
|
|
|
48-49 |
C |
p.
|
artikel
|
| 304 |
Safe, non-surgical retrieval of foreign bodies from the small bowel
|
Riccioni, Maria Elena
|
|
|
48-49 |
C |
p.
|
artikel
|
| 305 |
Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses
|
Bonovas, Stefanos
|
|
2018
|
48-49 |
C |
p. 43-47
|
artikel
|
| 306 |
Scoring systems for risk stratification in upper and lower gastrointestinal bleeding
|
Radaelli, Franco
|
|
|
48-49 |
C |
p.
|
artikel
|
| 307 |
Screening and surveillance of hereditary upper GI cancers
|
Wu, Lianlian
|
|
|
48-49 |
C |
p.
|
artikel
|
| 308 |
Screening for and surveillance of premalignant conditions of the stomach
|
Luzko, Irina
|
|
|
48-49 |
C |
p.
|
artikel
|
| 309 |
Serrated polyposis syndrome; epidemiology and management
|
Carballal, S.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 310 |
Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?
|
Pouillon, Lieven
|
|
2018
|
48-49 |
C |
p. 17-25
|
artikel
|
| 311 |
Should we use vedolizumab as mono or combo therapy in ulcerative colitis?
|
Hedin, Charlotte
|
|
2018
|
48-49 |
C |
p. 27-34
|
artikel
|
| 312 |
Small Bowel Capsule Endoscopy and artificial intelligence: First or second reader?
|
Piccirelli, Stefania
|
|
|
48-49 |
C |
p.
|
artikel
|
| 313 |
Striving for quality improvement: can artificial intelligence help?
|
Sinonquel, P.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 314 |
Surgery in ulcerative colitis: When? How?
|
Gallo, Gaetano
|
|
2018
|
48-49 |
C |
p. 71-78
|
artikel
|
| 315 |
Symptoms of PBC – Pathophysiology and management
|
Khanna, Amardeep
|
|
2018
|
48-49 |
C |
p. 41-47
|
artikel
|
| 316 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 317 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 318 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 319 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 320 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 321 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 322 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 323 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 324 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 325 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 326 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 327 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 328 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 329 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 330 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 331 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 332 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 333 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 334 |
Table of Contents
|
|
|
|
48-49 |
C |
p.
|
artikel
|
| 335 |
Tangible pathologies in functional dyspepsia
|
Walker, Marjorie M.
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 336 |
Targeted and immunotherapy in the era of personalised gastric cancer treatment
|
Catanese, Silvia
|
|
|
48-49 |
C |
p.
|
artikel
|
| 337 |
Targeting anti-fibrotic pathways in Crohn’s disease – The final frontier?
|
Ma, Christopher
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 338 |
Tests of intestinal mucosal hyperpermeability: Many diseases, many biomarkers and a bright future
|
Webb, Dominic-Luc
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 339 |
The complexity of cancer origins at the gastro-oesophageal junction
|
Bornschein, Jan
|
|
|
48-49 |
C |
p.
|
artikel
|
| 340 |
The contribution of EUS to the management of endoscopic and surgical complications
|
Tehami, N.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 341 |
The endoscopic management of oesophageal strictures
|
Norton, Benjamin Charles
|
|
|
48-49 |
C |
p.
|
artikel
|
| 342 |
The evolving role of device-assisted enteroscopy: The state of the art as of August 2023
|
Yamamoto, Hironori
|
|
|
48-49 |
C |
p.
|
artikel
|
| 343 |
The evolving role of small-bowel capsule endoscopy
|
Pecere, Silvia
|
|
|
48-49 |
C |
p.
|
artikel
|
| 344 |
The exposome as a target for primary prevention and a tool for early detection of pancreatic cancer
|
Lauri, Gaetano
|
|
|
48-49 |
C |
p.
|
artikel
|
| 345 |
The immune system and microbiome in pregnancy
|
Fuhler, G.M.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 346 |
The impact of biologics in surgical outcomes in ulcerative colitis
|
Argollo, Marjorie C.
|
|
2018
|
48-49 |
C |
p. 79-87
|
artikel
|
| 347 |
The impact of modulating the gastrointestinal microbiota in cancer patients
|
Morkūnas, Egidijus
|
|
|
48-49 |
C |
p.
|
artikel
|
| 348 |
The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease
|
Picardo, Sherman
|
|
|
48-49 |
C |
p.
|
artikel
|
| 349 |
The impact of recent next generation sequencing and the need for a new classification in gastric cancer
|
Businello, Gianluca
|
|
|
48-49 |
C |
p.
|
artikel
|
| 350 |
The influence of the gastric microbiota in gastric cancer development
|
Pereira-Marques, Joana
|
|
|
48-49 |
C |
p.
|
artikel
|
| 351 |
The interpretation of liver function tests in pregnancy
|
Guarino, Maria
|
|
|
48-49 |
C |
p.
|
artikel
|
| 352 |
The management of mid & proximal oesophageal squamous cell carcinoma
|
Wong, Ian
|
|
2018
|
48-49 |
C |
p. 85-90
|
artikel
|
| 353 |
The microbiome-driven impact of western diet in the development of noncommunicable chronic disorders
|
Severino, Andrea
|
|
|
48-49 |
C |
p.
|
artikel
|
| 354 |
The optimal use of blood components in the management of gastrointestinal bleeding
|
Donovan, Killian
|
|
|
48-49 |
C |
p.
|
artikel
|
| 355 |
The pros and cons of gastric bypass surgery – The role of the Roux-limb
|
Björklund, Per
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 356 |
Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology
|
Udomkarnjananun, Suwasin
|
|
|
48-49 |
C |
p.
|
artikel
|
| 357 |
Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS
|
Benno, P.
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 358 |
The role of artificial intelligence in Barrett's esophagus: Current status and future challenges
|
van Eijck van Heslinga, R.A.H.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 359 |
The role of colonoscopy and endotherapy in the management of lower gastrointestinal bleeding
|
Sengupta, Neil
|
|
|
48-49 |
C |
p.
|
artikel
|
| 360 |
The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer
|
Jeene, Paul M.
|
|
2018
|
48-49 |
C |
p. 53-59
|
artikel
|
| 361 |
The role of diet in inflammatory bowel disease: A comprehensive review of the literature
|
Faggiani, Ilaria
|
|
|
48-49 |
C |
p.
|
artikel
|
| 362 |
The role of diet in shaping human gut microbiota
|
Rinninella, Emanuele
|
|
|
48-49 |
C |
p.
|
artikel
|
| 363 |
The role of microbiome in the development of gluten-related disorders
|
Catassi, Giulia
|
|
|
48-49 |
C |
p.
|
artikel
|
| 364 |
The role of radiology in diagnosing gastrointestinal tract perforation
|
Kulinna-Cosentini, Christiane
|
|
|
48-49 |
C |
p.
|
artikel
|
| 365 |
The role of surgery in advanced disease for esophageal and junctional cancer
|
Mönig, Stefan
|
|
2018
|
48-49 |
C |
p. 91-96
|
artikel
|
| 366 |
The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy
|
Dean, Nathan J.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 367 |
The role of the microbiome in immune checkpoint inhibitor colitis and hepatitis
|
Ryan, Thomas
|
|
|
48-49 |
C |
p.
|
artikel
|
| 368 |
The Rome IV: Irritable bowel syndrome - A functional disorder
|
Hellström, Per M.
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 369 |
The use of endoscopic ultrasound in the diagnosis and management of portal hypertension
|
Laleman, Wim
|
|
|
48-49 |
C |
p.
|
artikel
|
| 370 |
The use of endoscopic ultrasound in the management of post-surgical and pancreatic fluid collections
|
Trieu, Judy A.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 371 |
Towards tolerance in liver transplantation
|
Toti, L.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 372 |
Traditional septotomy or Z-POEM for Zenker's diverticulum
|
Kaminski, M.F.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 373 |
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicine
|
Sequier, Léa
|
|
|
48-49 |
C |
p.
|
artikel
|
| 374 |
Treatment targets in IBD: is it time for new strategies?
|
Fanizzi, Fabrizio
|
|
|
48-49 |
C |
p.
|
artikel
|
| 375 |
“Unraveling the mysteries of IBD: Innovations and insights into the management of Crohn's disease and ulcerative colitis”
|
D'Amico, Ferdinando
|
|
|
48-49 |
C |
p.
|
artikel
|
| 376 |
Updates in the diagnosis and management of coeliac disease
|
Shiha, Mohamed G.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 377 |
Updates in the diagnosis and management of non-ampullary small-bowel polyposis
|
Lucaciu, Laura
|
|
|
48-49 |
C |
p.
|
artikel
|
| 378 |
Updates in the diagnosis and management of small-bowel Crohn's disease
|
Carretero, Cristina
|
|
|
48-49 |
C |
p.
|
artikel
|
| 379 |
Updates in the diagnosis and management of small-bowel tumors
|
Vlachou, Erasmia
|
|
|
48-49 |
C |
p.
|
artikel
|
| 380 |
Updates on the diagnosis and management of cryptogenic multifocal ulcerative stenosing enteropathy (CMUSE) and non-steroidal enteropathy
|
Moreels, Tom G.
|
|
|
48-49 |
C |
p.
|
artikel
|
| 381 |
Use of immunosuppression in non-transplant hepatology
|
Ronca, Vincenzo
|
|
|
48-49 |
C |
p.
|
artikel
|
| 382 |
Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders
|
Al-Saffar, Ahmad
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 383 |
Variant syndromes of primary biliary cholangitis
|
Schulz, Lisa
|
|
2018
|
48-49 |
C |
p. 55-61
|
artikel
|
| 384 |
What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?
|
Ma, Christopher
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 385 |
What is the role of histopathology in the evaluation of disease activity in Crohn's disease?
|
Pai, Rish K.
|
|
2019
|
48-49 |
C |
p.
|
artikel
|
| 386 |
When all else fails - Radiological management of severe gastrointestinal bleeding
|
Loffroy, Romaric
|
|
|
48-49 |
C |
p.
|
artikel
|
| 387 |
Which evidence for a treat to target strategy in ulcerative colitis?
|
Marchal Bressenot, Aude
|
|
2018
|
48-49 |
C |
p. 3-8
|
artikel
|
| 388 |
Wilson’s disease- management and long term outcomes
|
Socha, Piotr
|
|
|
48-49 |
C |
p.
|
artikel
|
Tijdschrift beschrijving